Tc-99m MIBI scintigraphy in patients with lung cancer comparison with CT and fluorine-18 FDG PET imaging

Clinical Nuclear Medicine

Volumn 22, Issue 4, 1997, Pages 243-249

  Wang, Hui ^b   Maurea, Simone ^a,c   Mainolfi, Ciro ^a   Fiore, Francesco ^a   Gravina, Adriano ^a   Panico, Maria Rosaria ^a   Bazzicalupo, Lucio ^a   Salvatore, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c NONE   (Italy)

Author keywords

CT; Diagnostic Imaging; Lung Cancer; PET; SPECT

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG CANCER; LUNG SCINTISCANNING; MALE; QUANTITATIVE DIAGNOSIS;

EID: 0030895056     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199704000-00008     Document Type: Article

References (25)

1. Abdel-Dayem HM, Scott A, Macapinlac H et al: Tracer imaging in lung cancer. Eur J Nucl Med 21:57, 1994.
2. Kubota K, Matsuzawa T, Fujiwara T, et al: Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 31:1927, 1990.
3. Dewan NA, Gupta NC, Redepenning LS, et al: Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest 104:997, 1993.
4. Gupta NC, Frank AR, Dewan NA, et al: Solitary pulmonary nodudes: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 184:441, 1992.
5. Wahl RL, Quint LE, Greenough RL, et al: Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion images: preliminary prospective evaluation. Radiology 191:371, 1994.
6. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, et al: Uptake of the cation hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vivo. Cancer Research 50:2198, 1990.
7. Maublant JC, Zhang Z, Rapp M, et al: In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 34:1949, 1993.
8. Aktolun C, Bayhan H, Kir M: Clinical experience with Tc-99m-MIBI imaging in patients with malignant tumors: preliminary results and comparison with TI-201. Clin Nucl Med 17:171, 1992.
9. Hassan IM, Sahweil A, Constantinides C, et al: Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 14:333, 1989.
10. Aktolun C, Bayhan H, Pabuccu Y, et al: Assessment of tumor necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: comparison with CT scan. Eur J Nucl Med 21:973, 1994.
11. Kao CH, Wang SJ, Lin WY, et al: Differentiation of single solid lesions in the lungs by mears of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 20:249, 1993.
12. Basoglu T, Sahin M, Coskun C, et al: Technetium-99m-tetrofosmin uptake in malignant lung tumours. Eur J Nucl Med 22:687, 1995
13. Sasaki M, Ichiya Y, Kuwabara Y, et al: The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography. Eur J Nucl Med 23:741, 1996.
14. Crane P, Laliberté R, Heminway S, et al: Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 20:20, 1993.
15. Chiu MI, Kronauge JF, Piwnica-Worms D: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisoburysonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 31:1646, 1990.
16. Baillet G, Albuquerque L, Chen Q, et al: Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 21: 1061, 1994.
17. Khalkhali I, Mena I, Diggles LL: Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 21:357, 1994.
18. Maurea S, Lastoria S, Klain M, et al: Non-Hodgkin's lymphoma in a patient with follicular thyroid cancer: the role of Tc-99m methoxy isobutyl isonitrile imaging. J Nucl Biol Med 38:18, 1994; 1994.
19. Nemec J. Nyvltova O, Blazek T, et al: Positive thyroid cancer scintigraphy using technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 23:69, 1996.
20. Ziegels P, Nocaudie M, Huglo D, et al: Comparision of technctium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas. Eur J Nucl Med 22:126, 1995.
21. Podoloff DA, Kim EE, Haynie TP, et al: Comparison of Tc-99m-sestamibi SPECT and F-18-FDG glucose PET in the evaluation of patient with malignancy, J Nucl Med (Abstract) 33:858, 1992.
22. Wahl RL, Hutchins GD, Buchsboaum DJ, et al: 18-F-2-deoxy-2-fluoro-deoxyglucose uptake into human tumor xenografts. Cancer 67:1544, 1991.
23. Chiti A, Maffioli LS, Infante M, et al: Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT. J Nucl Med 37:938, 1996.
24. Hamberg LM, Hunter GJ, Alpert NM, et al: The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 35:1308, 1994.
25. Keyes JW, Jr. SUV: standard uptake or silly useless value? J Nucl Med 36:1836, 1995.